These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37724669)

  • 1.
    Banerjee G; Papri SR; Satapathy SK; Banerjee P
    Curr Pharm Biotechnol; 2024; 25(4):426-433. PubMed ID: 37724669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.
    Miura K; Ohnishi H
    World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives.
    Han Y; Li L; Wang B
    Front Med; 2022 Oct; 16(5):667-685. PubMed ID: 36318353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Probiotics in Gut Microbiome and Metabolome in Non-Alcoholic Fatty Liver Disease Mouse Model: A Comparative Study.
    Wu T; Zeng Z; Yu Y
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792849
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jian H; Liu Y; Wang X; Dong X; Zou X
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.
    Zhang L; Wang Y; Wu F; Wang X; Feng Y; Wang Y
    Int J Biol Macromol; 2022 Jan; 196():23-34. PubMed ID: 34920070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of
    Nishiyama M; Ohtake N; Kaneko A; Tsuchiya N; Imamura S; Iizuka S; Ishizawa S; Nishi A; Yamamoto M; Taketomi A; Kono T
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32245128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of alive and pasteurized Akkermansia muciniphila on normal diet-fed mice.
    Ashrafian F; Keshavarz Azizi Raftar S; Shahryari A; Behrouzi A; Yaghoubfar R; Lari A; Moradi HR; Khatami S; Omrani MD; Vaziri F; Masotti A; Siadat SD
    Sci Rep; 2021 Sep; 11(1):17898. PubMed ID: 34504116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the probiotic
    Xu R; Zhang Y; Chen S; Zeng Y; Fu X; Chen T; Luo S; Zhang X
    Crit Rev Microbiol; 2023 Mar; 49(2):151-176. PubMed ID: 35272549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat-Inactivated
    Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis.
    Kim S; Lee Y; Kim Y; Seo Y; Lee H; Ha J; Lee J; Choi Y; Oh H; Yoon Y
    Appl Environ Microbiol; 2020 Mar; 86(7):. PubMed ID: 31953338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akkermansia muciniphila Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism.
    Xia J; Lv L; Liu B; Wang S; Zhang S; Wu Z; Yang L; Bian X; Wang Q; Wang K; Zhuge A; Li S; Yan R; Jiang H; Xu K; Li L
    Microbiol Spectr; 2022 Feb; 10(1):e0159621. PubMed ID: 35107323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
    Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
    Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of
    Hasani A; Ebrahimzadeh S; Hemmati F; Khabbaz A; Hasani A; Gholizadeh P
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34623232
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Yan J; Sheng L; Li H
    Gut Microbes; 2021; 13(1):1984104. PubMed ID: 34674606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Qu D; Chen M; Zhu H; Liu X; Cui Y; Zhou W; Zhang M
    Biochem Biophys Res Commun; 2023 Dec; 684():149131. PubMed ID: 37866242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates.
    Khan A; Ding Z; Ishaq M; Bacha AS; Khan I; Hanif A; Li W; Guo X
    Int J Biol Sci; 2021; 17(3):818-833. PubMed ID: 33767591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Synbiotic Combination of
    Juárez-Fernández M; Porras D; Petrov P; Román-Sagüillo S; García-Mediavilla MV; Soluyanova P; Martínez-Flórez S; González-Gallego J; Nistal E; Jover R; Sánchez-Campos S
    Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.